Estrogen Supplementation and Bone Health in Women With CF
Phase 4
75
about 3.8 years
0–100
Female only
1 site in MD
About this study
Researchers are testing whether estrogen supplementation, including transdermal estrogen patches, affects bone health in women with cystic fibrosis. The trial also explores the feasibility of using transdermal estrogen and compares different forms of hormonal contraception on bone health. Participants will have their hormone levels, bone density, and quality of life assessed over time.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Progesterone
- 2.Take Transdermal estrogen
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
progesterone (Progestin hormone; prepares uterus lining), Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) (Estrogen Receptor Agonists)
oral (Oral Capsule), transdermal
Secondary: Change in quality of life as assessed by Cystic Fibrosis Respiratory Symptom Diary - Chronic Respiratory Infection Symptom Score (CFRSD-CRISS) questionnaire
Respiratory